Toward a cure for diabetes: iPSC and ESC ‐derived islet cell transplantation trials
Journal of Diabetes Investigation · 2025-03 · 16 (3) · 384-388
DOI: 10.1111/jdi.14366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 22.11.2024. Verfasst von Junji Fujikura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Induced Pluripotent Stem Cells, Diabetes Mellitus, Type 1, Embryonic Stem Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Advancements in regenerative medicine, particularly through the use of induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), are garnering substantial attention as potential solutions to the limited availability of donors, leading to prolonged waiting periods for people with type 1 diabetes who require transplantation of pancreatic islets from deceased donors. The promising outcomes from recent clinical trials suggest that transplantation of iPSC- or ESC-derived islet cells could pave the way for more effective and broadly accessible treatment options. This progress holds potential not only for individuals with type 1 diabetes but may also extend to type 2 diabetes treatment in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
- Orizuru Therapeutics, Inc., Fujisawa, Kanagawa, Japan.
- Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
- Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan.
ORCID-Profile: Junji Fujikura, Takayuki Anazawa, Taro Toyoda, Ryo Ito, Yasuko Kimura, Daisuke Yabe
Förderung
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Fujikura, J., Anazawa, T., Toyoda, T., Ito, R., Kimura, Y., & Yabe, D. (2025). Toward a cure for diabetes: iPSC and ESC ‐derived islet cell transplantation trials. Journal of Diabetes Investigation, 16(3), 384-388. https://doi.org/10.1111/jdi.14366
Vancouver
Fujikura J, Anazawa T, Toyoda T, Ito R, Kimura Y, Yabe D. Toward a cure for diabetes: iPSC and ESC ‐derived islet cell transplantation trials. Journal of Diabetes Investigation. 2025;16(3):384-388. doi:10.1111/jdi.14366
BibTeX
@article{Fujikura2025,
author = {Fujikura, Junji and Anazawa, Takayuki and Toyoda, Taro and Ito, Ryo and Kimura, Yasuko and Yabe, Daisuke},
title = {Toward a cure for diabetes: iPSC and ESC ‐derived islet cell transplantation trials},
journal = {Journal of Diabetes Investigation},
year = {2025},
volume = {16},
number = {3},
pages = {384--388},
doi = {10.1111/jdi.14366}
}
EUVIMED